Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Op-Eds
Unholy Alliance
States are embroiled in a nasty squabble with their business partner of seven years: Big Tobacco. <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office”…
Op-Eds
The UN vs. Technology
With diseases such as malaria, tuberculosis, and AIDS ravaging the world's poor—and perhaps a flu pandemic in the offing—the United Nations'…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. SCIENCE The Food and Drug Administration plans to investigate the alleged link between cell phone use…
Op-Eds
Top Ten Junk Science Stories of the Past Decade
My web site JunkScience.com celebrated its 10th anniversary on April 1, 2006. To mark the event, this column spotlights…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH A New Jersey jury awards $4.5 million in a lawsuit against Merck & Co. involving…
Newsletter
The Competitive Enterprise Institute Daily Update
1. BUSINESS Wal-Mart announces a new initiative to revitalize struggling urban neighborhoods. CEI Expert Available to Comment: Adjunct Analyst…